FLOWERS FOODS, INC (FLO): what the price assumes

boothcheck covers FLOWERS FOODS, INC (FLO) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-07-26.

Generated: 2026-08-30 · Source: https://boothcheck.com/report/FLO

Headline

FieldValue
TickerFLO
CompanyFLOWERS FOODS, INC
Sector / IndustryConsumer Defensive
Current price$7.07/sh
CompositionBranded Retail 66% / Other 34%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Trailing margin (depressed year)2.7%
Multiple paid10x mid-cycle operating income

The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 6% cost of capital with 4% terminal growth over a 5-year stage (computed at the 6% minimum rate; the CAPM rate 5.2% sits below it).

How unusual the bet is: within-range (limited comparison data)

ReferenceValue
vs own history-0.28σ
cohort percentile (of 69 peers)7

Valuation X-Ray

The price is justified by relative-multiple and growth-DCF; asset-based/earnings-power land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset3.17x5expensive
Earnings2.02x4expensive
Relative0.74x3justifies
Growth0.69x3justifies

Families that justify the price: Relative, Growth Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 3.9%); the inversion above states its own rate.

Per-Model Detail (n=15)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowthno
DCF Exit MultipleGrowth$12.350.57xyesExit EV/EBITDA: 10.3x / 12.3x / 14.3x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelative$7.730.91xyesP/E 22x (static sector reference · 2026-04), scenarios: 18.6x / 22.0x / 25.4x (bear / base = reference held flat / bull), EV/EBITDA 14x
Simple DDMGrowth$10.280.69xyesDPS $0.50, g=4.2% (sustainable: ROE (TTM) × retention; not the terminal-growth assumption), ke=9.3%
Two-Stage DDMGrowth$0.06117.83xyesStage 1: -88% for 5yr, Stage 2: 3.5% perpetual (excluded from median)
Simple Excess ReturnAsset$2.812.52xyesBV/sh $6.24, ROE (TTM) 4.2%, ke 9.3%
Two-Stage Excess ReturnAsset$1.823.88xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$5.021.41xyesRev $5.2B, growth 3% (input: historical growth; tapered), Terminal P/S: 0.2x / 0.3x / 0.3x (bear / base = today's held flat / bull, cap 8x)
Growth-Adjusted P/ERelativeno
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$13.020.54xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.27B × (1−25%) / WACC 3.9% → EPV (no growth)
Residual IncomeAsset$1.504.71xyesBV $6.24 + 5yr PV of (ROE (TTM) 4.2% − Kₑ 9.3%) × BV; BV grows 2.7%/yr
Graham NumberAsset$6.041.17xyes√(22.5 × EPS $0.26 × BVPS $6.24) — Graham's conservative floor
EV/EBITDA RelativeRelative$9.520.74xyesEBITDA $0.31B × sector EV/EBITDA 14.0x
FCF YieldEarnings$4.521.56xyesFCF $306.1M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$2.862.47xyesSBC-adj FCF $0.27B (FCF $0.31B − SBC $0.03B) capitalized at Kₑ
Ben Graham FormulaEarnings$0.2232.14xyesEPS $0.26 × (8.5 + 2×-5.0%) × (4.4 / 5.3%) (excluded from median)
ROIC-Justified P/BAsset$2.233.17xyesBV $6.24 × (ROIC 1.4% / WACC 3.9%)
P/Sales SectorRelative$49.270.14xyesRevenue $5.22B × sector P/S 2.0x
PEG Fair ValueRelativeno
Earnings YieldEarnings$2.812.52xyesEPS $0.26 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

Only one reportable economic unit is present in the current topology source. Consolidated operating lenses remain available, but there is no multi-unit decomposition.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Bakery (single reportable segment)operatingenterprise5.3B reported-currencywithheldunresolved no unit value

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

FieldValue
Net debt$1.6b
Net debt / NOPAT (after-tax)6.36x
Net debt / operating income (pre-tax)4.77x
Interest coverage4.2x
Share count CAGR (buyback)-0.1%
Burning cashno

Leverage and coverage are computed on normalized mid-cycle operating income (mid-cycle margin 6.6%); the trailing year was depressed.

Bullet Takeaways

Bull Case

Bread is a scale business disguised as a commodity, and the shape of the industry is the whole moat. The 10-K names the field directly: the "baking industry consists of Bimbo Bakeries USA (BBU), Flowers Foods, and The Campbell's Company, under the Pepperidge Farm brand, along with a number of smaller independent regional bakers, local bakeries, and retailer-owned bakeries". Fresh bread has a shelf life measured in days, which means the product cannot be made centrally and shipped cheaply; it has to be baked near the customer and delivered to the shelf several times a week. Building that lattice of plants and routes from scratch is not a thing a challenger does, and it is why a category with thin margins has stayed a three-player game for decades.

The brand shelf that sits on top of it is real. Nature's Own, Dave's Killer Bread, Canyon Bakehouse, Wonder and Tastykake occupy positions that took decades to establish, and even the least fashionable of them holds ground: the company reports that "Wonder's Classic White loaf is the #2 UPC in the white loaf segment based on dollars and units in the U.S.". In February 2025 the company added Simple Mills, a natural better-for-you brand in crackers, cookies, snack bars and baking mixes, which is the first serious attempt to point the distribution network at a category that is growing rather than shrinking.

The reported profit line badly understates what the business earns, and the reason is disclosed rather than inferred. Income from operations was $174.0 million in fiscal 2025 against $348.3 million the year before, and inside that gap sits a non-cash impairment charge of $136.0 million taken in the fourth quarter against two legacy brand trademarks. Strip that single entry out and the operating line is close to where it was. The first sixteen weeks of fiscal 2026 make the same point without any adjustment at all: income from operations of $79.8 million on net sales of $1,571.6 million.

Context from the cohort matters here, because every large packaged-food company has spent the last two years writing down brands bought when the category looked permanent. CAG converts 0.3% of $11.2 billion of revenue into operating profit with revenue down 4.7%, KHC is negative at -18.9%, GIS runs 4.8% on revenue down 5.4%, and SJM 4.0%. Against that, a bakery earning around five cents on the sales dollar in its most recent quarter is not the distressed member of the group. It is roughly in the middle of a group that is uniformly under pressure.

What changed in May is the part a shareholder should weigh most carefully. The board reset the payout, and the arithmetic behind it is straightforward: dividends absorbed $209.3 million in fiscal 2025, and the new rate takes roughly half of that back inside the company. Against $500.0 million of 5.750% notes due 2035 and $300.0 million of 6.200% notes due 2055 issued in February 2025 to fund the acquisition, retaining that much every year is the single most valuable thing management can do with it. Cutting a dividend is the least popular decision available to a board of a company like this, which is some evidence that it was made on the numbers rather than for effect.

Bear Case

The variable with the most leverage over this business is not wheat, or freight, or even the shelf price. It is whether people keep eating bread, and the company itself now lists the reason they might not. Among its risk factors the 10-K names "certain weight loss drugs and glucagon-like peptide 1 (GLP-1) agonists, which may suppress a person's appetite, may impact demand for our products", alongside consumer perceptions about processed wheat and sugar. A category headwind driven by pharmacology is not something a bakery can price or market its way out of, and unlike a commodity cycle it does not mean-revert.

The volume data is already consistent with that. Fiscal 2025 sales rose 3.0%, but units fell 2.0% and price and mix subtracted a further 0.8%; the entire increase came from the Simple Mills acquisition and an extra week in the year. In the first sixteen weeks of fiscal 2026, net sales of $1,571.6 million against $1,554.2 million represent barely more than one percent of growth, and income from operations went the other way, to $79.8 million from $85.1 million. A business losing units every year is running a treadmill where price increases have to cover the volume it just lost before they do anything for shareholders.

The balance sheet turned that from a slow problem into a timed one. To buy Simple Mills the company issued $500.0 million of notes bearing 5.750% due 2035 and $300.0 million bearing 6.200% due 2055 in February 2025, and net borrowings now stand at roughly 1.7 billion dollars against essentially no cash held. The credit agreement carries a maximum leverage covenant of 3.75 to 1.00, which the company was permitted to raise to 4.00 to 1.00 for four consecutive quarters following an acquisition and did. The agreement was subsequently amended to add a pricing tier covering the case where the company's ratings fall to Ba2 or below at Moody's and BB or below at S&P. Lenders do not write that clause for companies they expect to stay where they are.

Customer power sits on the other side of every one of those negotiations. Ten customers accounted for 57.7% of fiscal 2025 sales and Walmart with Sam's Club alone for 21.5%. That concentration is normal for the category, which is precisely the point: CPB discloses in its own filing that "Our five largest customers accounted for approximately 47 % of our consolidated net sales in 2025, 2024, and 2023", so every supplier in the aisle is negotiating from the same weak position against the same handful of buyers. When volumes fall industry-wide, the retailer decides who keeps the shelf space.

And the dividend reset, which reads as prudence from the balance-sheet side, reads differently from the holder's. A board that halves a payout it has raised for years is telling you its own forecast changed. The shares moved from the S&P MidCap 400 to the SmallCap 600 in May 2026. Neither event changes what the bakeries produce. Both change who owns the stock and on what expectation.

Valuation

Any multiple built on this company's reported profit right now is largely measuring a write-down, so that is where the section has to start. Income from operations was $174.0 million for fiscal 2025 against $348.3 million the year before, and a non-cash impairment of $136.0 million against two legacy trademarks accounts for most of the difference. On the same reported basis, the trailing twelve months through the quarter ended April 25, 2026 come to about $168.7 million, and they carry that same charge. The underlying business did not halve.

That distortion is exactly what splits the methods, and the split is unusually wide. The asset-value lens and the earnings-power methods both land well below the price, because both are reading a depressed trailing return on a book value that has just been reduced: the price sits roughly 180% above where the asset lens comes out and roughly 110% above the earnings-power lens. Peer multiples and the discounted cash-flow approaches land above the price instead. When the backward-looking methods say expensive and the forward-looking ones say cheap on the same company, the disagreement is usually about which year is representative, and here it plainly is.

One of the earnings-power methods answers that question directly, and it is worth following. It averages operating profit across five years and adds back one-time charges before capitalizing the result, and the figure it uses is far above the trailing reported line. Read that way, today's price is not paying for a company earning three cents of operating profit on the sales dollar. It is paying for one that has recently earned around twice that and is being marked at its worst reported year in a decade. Whether that is an opportunity or an accurate forecast depends entirely on the volume trend, not on the accounting.

Against the cohort the shares sit in the lower half of the peer multiple range, and the peers give the honest frame. CPB converts 11.3% of revenue into operating profit and MZTI 11.3%, POST 10.1% on revenue growing 7.2%; at the other end CAG manages 0.3% with revenue down 4.7% and GIS 4.8% with revenue down 5.4%. A bakery earning around five cents on the sales dollar in its most recent quarter sits between those two groups. The engine's own read of what the price implies here carries low reliability, which is the right amount of confidence to place in any single inversion of a company mid-write-down.

The balance sheet is what bounds all of it. Net borrowings of roughly 1.7 billion dollars sit against a balance sheet holding almost nothing liquid, and the fiscal 2025 operating line was $174.0 million. That is a large obligation relative to current reported profit, which is why the payout reset in May matters more than its headline yield: roughly a hundred million dollars a year that used to leave the company now stays in it, and the share count has been flat for four years, so none of it is being handed back through issuance either. The question the price is really asking is not whether the bakeries are worth something. It is how many more years of falling units the debt has to be carried through.

Catalysts

The decision that reset the investment case came on May 21, 2026. Alongside first-quarter results, the 10-Q records that "the Board of Directors reset the dividend to an annual rate of $ 0.50 per share and declared a quarterly dividend of $ 0.1250 per share of the company's common stock, payable on June 26, 2026". The prior quarterly rate had been $0.2475, and the annual rate had risen every year through fiscal 2025. Dividends absorbed $209.3 million in fiscal 2025, so the reset retains roughly half of that inside the company each year, all of it available for the notes issued to fund the Simple Mills acquisition.

The quarter it accompanied showed why. Net sales for the sixteen weeks ended April 25, 2026 were $1,571.6 million against $1,554.2 million a year earlier, and income from operations fell to $79.8 million from $85.1 million, with the company citing a challenging consumer environment. Profit for the quarter came in below the prior year, which management attributed to the lower operating result, higher interest expense from funding the acquisition, and a significantly higher effective tax rate.

Two other dated items belong in the picture. The shares moved from the S&P MidCap 400 into the S&P SmallCap 600 at the open on May 18, 2026, a mechanical change in the ownership base rather than in the business. And in July the company ran a Nature's Own consumer campaign tied to Make-A-Wish America, which matters only as evidence that marketing spend behind the core brand is being maintained through the reset rather than cut alongside it. Second-quarter results are scheduled for August 14, 2026, and the line to watch is units rather than sales dollars, because pricing has already been carrying this business for longer than pricing usually can.

Peer Cohorts (Per Segment, With Filing Citations)

Bakery (single reportable segment) (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

FY2025 10-K consolidated statements of income · Q1 FY2026 10-Q, filed May 2026 · FY2025 10-K, filed February 2026 · FY2025 10-K management discussion · S&P Dow Jones Indices announcement, May 2026 · company announcement, July 21, 2026

View the full interactive FLO report on boothcheck